C. Glinge, S. Rossetti, L. Bruun Oestergaard, N. Stampe, M. Ravn Jacobsen, L. Koeber, T. Engstroem, C. Torp-Pedersen, G. Gislason, R. Jabbari, J. Tfelt‐Hansen
{"title":"不明原因心力衰竭的家族聚类——丹麦全国队列研究","authors":"C. Glinge, S. Rossetti, L. Bruun Oestergaard, N. Stampe, M. Ravn Jacobsen, L. Koeber, T. Engstroem, C. Torp-Pedersen, G. Gislason, R. Jabbari, J. Tfelt‐Hansen","doi":"10.1093/europace/euac053.008","DOIUrl":null,"url":null,"abstract":"\n \n \n Type of funding sources: Public grant(s) – EU funding. Main funding source(s): This project has received funding from the European Union’s Horizon 2020 research and innovation programme under acronym ESCAPE-NET, registered under grant agreement No 733381, and the European Union’s COST programme under acronym PARQ, registered under grant agreement No CA19137.\n \n \n \n Although family history of heart failure (HF) is associated with increased risk of HF, the extent to which a family history contributes to the risk of HF needs further investigation.\n \n \n \n To determine whether a family history of unexplained HF in first-degree relatives (children or sibling) increases the rate of unexplained HF.\n \n \n \n Using Danish nationwide registry data (1978-2017), we identified patients (probands) diagnosed with first unexplained HF (HF without any known comorbidities) in Denmark, and their first-degree relatives. All first-degree relatives were followed from the HF date of the proband and until an event of unexplained HF, exclusion diagnosis, death, emigration, or study end, whichever occurred first. Using the general population as a reference, we calculated adjusted standardized incidence ratios (SIR) of unexplained HF in the three groups of relatives using Poisson regression models.\n \n \n \n We identified 57,845 first-degree relatives to individuals previously diagnosed with unexplained HF. Having a family history was associated with a significantly increased unexplained HF rate of 2.08 (95% CI 1.82-2.38) (Figure 1). The estimate was higher among siblings (SIR 4.82 [95% CI 3.17-7.32]). Noteworthy, the rate of HF increased for all first-degree relatives when the proband was diagnosed with HF in a young age (≤50 years, SIR of 3.60 [95% CI 2.37-5.47]) and having >1 proband (SIR of 2.73 [95% CI 1.14-6.56]). The highest estimate of HF was observed if the proband was ≤40 years at diagnosis (6.12 [95% CI 3.39-11.05]) (Figure 2).\n \n \n \n A family history of unexplained HF was associated with a two-fold increased rate of unexplained HF among first-degree relatives. If the proband age was ≤40 years, the risk was six-folded. These findings suggest that screening families of unexplained HF with onset below 50 years is indicated.\n","PeriodicalId":11720,"journal":{"name":"EP Europace","volume":"77 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-05-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Familial clustering of unexplained heart failure - A Danish nationwide cohort study\",\"authors\":\"C. Glinge, S. Rossetti, L. Bruun Oestergaard, N. Stampe, M. Ravn Jacobsen, L. Koeber, T. Engstroem, C. Torp-Pedersen, G. Gislason, R. Jabbari, J. Tfelt‐Hansen\",\"doi\":\"10.1093/europace/euac053.008\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n \\n \\n Type of funding sources: Public grant(s) – EU funding. Main funding source(s): This project has received funding from the European Union’s Horizon 2020 research and innovation programme under acronym ESCAPE-NET, registered under grant agreement No 733381, and the European Union’s COST programme under acronym PARQ, registered under grant agreement No CA19137.\\n \\n \\n \\n Although family history of heart failure (HF) is associated with increased risk of HF, the extent to which a family history contributes to the risk of HF needs further investigation.\\n \\n \\n \\n To determine whether a family history of unexplained HF in first-degree relatives (children or sibling) increases the rate of unexplained HF.\\n \\n \\n \\n Using Danish nationwide registry data (1978-2017), we identified patients (probands) diagnosed with first unexplained HF (HF without any known comorbidities) in Denmark, and their first-degree relatives. All first-degree relatives were followed from the HF date of the proband and until an event of unexplained HF, exclusion diagnosis, death, emigration, or study end, whichever occurred first. Using the general population as a reference, we calculated adjusted standardized incidence ratios (SIR) of unexplained HF in the three groups of relatives using Poisson regression models.\\n \\n \\n \\n We identified 57,845 first-degree relatives to individuals previously diagnosed with unexplained HF. Having a family history was associated with a significantly increased unexplained HF rate of 2.08 (95% CI 1.82-2.38) (Figure 1). The estimate was higher among siblings (SIR 4.82 [95% CI 3.17-7.32]). Noteworthy, the rate of HF increased for all first-degree relatives when the proband was diagnosed with HF in a young age (≤50 years, SIR of 3.60 [95% CI 2.37-5.47]) and having >1 proband (SIR of 2.73 [95% CI 1.14-6.56]). The highest estimate of HF was observed if the proband was ≤40 years at diagnosis (6.12 [95% CI 3.39-11.05]) (Figure 2).\\n \\n \\n \\n A family history of unexplained HF was associated with a two-fold increased rate of unexplained HF among first-degree relatives. If the proband age was ≤40 years, the risk was six-folded. These findings suggest that screening families of unexplained HF with onset below 50 years is indicated.\\n\",\"PeriodicalId\":11720,\"journal\":{\"name\":\"EP Europace\",\"volume\":\"77 11\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-05-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EP Europace\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/europace/euac053.008\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EP Europace","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/europace/euac053.008","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
资助来源类型:公共资助-欧盟资助。主要资金来源:本项目已获得欧盟地平线2020研究和创新计划(缩写为ESCAPE-NET)和欧盟成本计划(缩写为PARQ)的资助,缩写为ESCAPE-NET,注册资助协议编号为733381。虽然心力衰竭家族史与心力衰竭风险增加有关,但家族史对心力衰竭风险的影响程度有待进一步调查。目的:确定一级亲属(子女或兄弟姐妹)有不明原因HF家族史是否会增加不明原因HF的发生率。利用丹麦全国登记数据(1978-2017),我们确定了在丹麦诊断为首次不明原因HF(无任何已知合共病的HF)的患者(先证)及其一级亲属。所有一级亲属从先证者HF发生之日起进行随访,直到不明原因HF事件、排除诊断、死亡、移民或研究结束,以先发生者为准。以普通人群为参考,我们使用泊松回归模型计算了三组亲属中不明原因HF的调整标准化发病率(SIR)。我们确定了57,845名以前被诊断为不明原因HF的个体的一级亲属。有家族史与不明原因HF发生率显著增加相关,为2.08 (95% CI 1.82-2.38)(图1)。兄弟姐妹的估计更高(SIR 4.82 [95% CI 3.17-7.32])。值得注意的是,当先证者在年轻时(≤50岁,SIR为3.60 [95% CI 2.37-5.47])和有>1个先证者(SIR为2.73 [95% CI 1.14-6.56])被诊断为HF时,所有一级亲属的HF发生率均增加。如果先证者诊断时年龄≤40岁,则HF的估计最高(6.12 [95% CI 3.39-11.05])(图2)。在一级亲属中,不明原因HF的家族史与不明原因HF的发生率增加两倍相关。如果先证者年龄≤40岁,则风险为6倍。这些发现表明,有必要筛查起病年龄在50岁以下的不明原因HF家族。
Familial clustering of unexplained heart failure - A Danish nationwide cohort study
Type of funding sources: Public grant(s) – EU funding. Main funding source(s): This project has received funding from the European Union’s Horizon 2020 research and innovation programme under acronym ESCAPE-NET, registered under grant agreement No 733381, and the European Union’s COST programme under acronym PARQ, registered under grant agreement No CA19137.
Although family history of heart failure (HF) is associated with increased risk of HF, the extent to which a family history contributes to the risk of HF needs further investigation.
To determine whether a family history of unexplained HF in first-degree relatives (children or sibling) increases the rate of unexplained HF.
Using Danish nationwide registry data (1978-2017), we identified patients (probands) diagnosed with first unexplained HF (HF without any known comorbidities) in Denmark, and their first-degree relatives. All first-degree relatives were followed from the HF date of the proband and until an event of unexplained HF, exclusion diagnosis, death, emigration, or study end, whichever occurred first. Using the general population as a reference, we calculated adjusted standardized incidence ratios (SIR) of unexplained HF in the three groups of relatives using Poisson regression models.
We identified 57,845 first-degree relatives to individuals previously diagnosed with unexplained HF. Having a family history was associated with a significantly increased unexplained HF rate of 2.08 (95% CI 1.82-2.38) (Figure 1). The estimate was higher among siblings (SIR 4.82 [95% CI 3.17-7.32]). Noteworthy, the rate of HF increased for all first-degree relatives when the proband was diagnosed with HF in a young age (≤50 years, SIR of 3.60 [95% CI 2.37-5.47]) and having >1 proband (SIR of 2.73 [95% CI 1.14-6.56]). The highest estimate of HF was observed if the proband was ≤40 years at diagnosis (6.12 [95% CI 3.39-11.05]) (Figure 2).
A family history of unexplained HF was associated with a two-fold increased rate of unexplained HF among first-degree relatives. If the proband age was ≤40 years, the risk was six-folded. These findings suggest that screening families of unexplained HF with onset below 50 years is indicated.